Derive M - Search Results

1

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, Salcedo-Magguilli M, Lemarié J, De Schryver N, Jalkanen V, Hicheur T, Garaud JJ, Cuvier V, Ferrer R, Bestle M, Pettilä V, Mira JP, Bouisse C, Mercier E, Vermassen J, Huberlant V, Vinatier I, Anguel N, Levy M, Laterre PF; ASTONISH investigators. François B, et al. Among authors: derive m. Lancet Respir Med. 2023 Oct;11(10):894-904. doi: 10.1016/S2213-2600(23)00158-3. Epub 2023 May 31. Lancet Respir Med. 2023. PMID: 37269870 Clinical Trial.

2

Osteopontin in sepsis: any role?

Derive M, Gibot S. Derive M, et al. Intensive Care Med. 2008 Dec;34(12):2134-5. doi: 10.1007/s00134-008-1275-5. Epub 2008 Sep 20. Intensive Care Med. 2008. PMID: 18807010 No abstract available.

3

Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats.

Gibot S, Massin F, Alauzet C, Derive M, Montemont C, Collin S, Fremont S, Levy B. Gibot S, et al. Among authors: derive m. Shock. 2009 Dec;32(6):633-7. doi: 10.1097/SHK.0b013e3181a53842. Shock. 2009. PMID: 19333144

4

Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Derive M, Massin F, Gibot S. Derive M, et al. Self Nonself. 2010 Jul;1(3):225-230. doi: 10.4161/self.1.3.12891. Epub 2010 Jul 2. Self Nonself. 2010. PMID: 21487478 Free PMC article.

5

Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury.

Derive M, Gibot S. Derive M, et al. Crit Care. 2011;15(6):1013. doi: 10.1186/cc10533. Epub 2011 Nov 30. Crit Care. 2011. PMID: 22136371 Free PMC article.

6

Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis.

Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S. Derive M, et al. J Immunol. 2012 Jun 1;188(11):5585-92. doi: 10.4049/jimmunol.1102674. Epub 2012 May 2. J Immunol. 2012. PMID: 22551551 Free PMC article. Clinical Trial.

7

Myeloid-derived suppressor cells control microbial sepsis.

Derive M, Bouazza Y, Alauzet C, Gibot S. Derive M, et al. Intensive Care Med. 2012 Jun;38(6):1040-9. doi: 10.1007/s00134-012-2574-4. Epub 2012 May 3. Intensive Care Med. 2012. PMID: 22552586

8

Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs.

Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, Lozniewski A, Leroy P, Tran N, Gibot S. Derive M, et al. Shock. 2013 Feb;39(2):176-82. doi: 10.1097/SHK.0b013e31827bcdfb. Shock. 2013. PMID: 23324887

9

Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate.

Derive M, Boufenzer A, Gibot S. Derive M, et al. Anesthesiology. 2014 Apr;120(4):935-42. doi: 10.1097/ALN.0000000000000078. Anesthesiology. 2014. PMID: 24270127 Free article.

10

TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction.

Boufenzer A, Lemarié J, Simon T, Derive M, Bouazza Y, Tran N, Maskali F, Groubatch F, Bonnin P, Bastien C, Bruneval P, Marie PY, Cohen R, Danchin N, Silvestre JS, Ait-Oufella H, Gibot S. Boufenzer A, et al. Among authors: derive m. Circ Res. 2015 May 22;116(11):1772-82. doi: 10.1161/CIRCRESAHA.116.305628. Epub 2015 Apr 3. Circ Res. 2015. PMID: 25840803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page